- Home
- OABI vs GHG Comparison
OABI vs GHG Comparison
Compare OABI & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- GHG
- Stock Information
- Founded
- OABI 2012
- GHG 2004
- Country
- OABI United States
- GHG China
- Employees
- OABI N/A
- GHG N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- GHG Hotels/Resorts
- Sector
- OABI Health Care
- GHG Consumer Discretionary
- Exchange
- OABI Nasdaq
- GHG Nasdaq
- Market Cap
- OABI 185.9M
- GHG 202.0M
- IPO Year
- OABI N/A
- GHG 2018
- Fundamental
- Price
- OABI $1.38
- GHG $2.12
- Analyst Decision
- OABI Strong Buy
- GHG
- Analyst Count
- OABI 3
- GHG 0
- Target Price
- OABI $7.00
- GHG N/A
- AVG Volume (30 Days)
- OABI 953.8K
- GHG 22.0K
- Earning Date
- OABI 05-08-2025
- GHG 06-24-2025
- Dividend Yield
- OABI N/A
- GHG 4.06%
- EPS Growth
- OABI N/A
- GHG N/A
- EPS
- OABI N/A
- GHG 0.15
- Revenue
- OABI $26,744,000.00
- GHG $184,055,595.00
- Revenue This Year
- OABI N/A
- GHG $19.02
- Revenue Next Year
- OABI $40.06
- GHG $8.26
- P/E Ratio
- OABI N/A
- GHG $14.08
- Revenue Growth
- OABI 27.07
- GHG N/A
- 52 Week Low
- OABI $1.22
- GHG $1.95
- 52 Week High
- OABI $4.96
- GHG $3.40
- Technical
- Relative Strength Index (RSI)
- OABI 39.15
- GHG 55.37
- Support Level
- OABI $1.22
- GHG $1.96
- Resistance Level
- OABI $1.42
- GHG $2.04
- Average True Range (ATR)
- OABI 0.08
- GHG 0.05
- MACD
- OABI 0.03
- GHG 0.02
- Stochastic Oscillator
- OABI 39.02
- GHG 100.00
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.